Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 2.18% to $163.72 on Tuesday, underperforming the broader market and key competitors like Eli Lilly and Johnson & Johnson during a positive trading session. The stock remains significantly below its 52-week high of $354.88. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slipped 2.18% to $163.72 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
Insulet Corp. closed 53.87% short of its 52-week high of $354.88, which the company reached on November 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Eli Lilly & Co. (LLY) rose 2.49% to $1,175.41, DexCom Inc. (DXCM) fell 1.24% to $74.75, and Johnson & Johnson (JNJ) rose 0.72% to $250.61.
Trading volume (1.1 M) remained 418,522 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1714ET